As of 2024-12-13, the Relative Valuation of Supernus Pharmaceuticals Inc (SUPN) is 8.84 USD. This relative valuation is based on P/E multiples. With the latest stock price at 36.85 USD, the upside of Supernus Pharmaceuticals Inc based on Relative Valuation is -76.0%.
The range of the Relative Valuation is 1.03 - 19.07 USD.
| Range | Selected | |
| Trailing P/E multiples | 13.7x - 17.6x | 15.0x |
| Forward P/E multiples | 9.8x - 18.7x | 13.9x |
| Fair Price | 1.03 - 19.07 | 8.84 |
| Upside | -97.2% - -48.2% | -76.0% |
| Date | P/E |
| 2024-12-11 | 34.08 |
| 2024-12-10 | 33.98 |
| 2024-12-09 | 33.92 |
| 2024-12-06 | 34.37 |
| 2024-12-05 | 34.21 |
| 2024-12-04 | 34.36 |
| 2024-12-03 | 34.24 |
| 2024-12-02 | 34.50 |
| 2024-11-29 | 33.82 |
| 2024-11-27 | 34.21 |
| 2024-11-26 | 33.42 |
| 2024-11-25 | 33.38 |
| 2024-11-22 | 33.50 |
| 2024-11-21 | 33.13 |
| 2024-11-20 | 33.40 |
| 2024-11-19 | 32.86 |
| 2024-11-18 | 32.60 |
| 2024-11-15 | 32.89 |
| 2024-11-14 | 33.46 |
| 2024-11-13 | 34.93 |
| 2024-11-12 | 34.98 |
| 2024-11-11 | 33.86 |
| 2024-11-08 | 33.85 |
| 2024-11-07 | 33.66 |
| 2024-11-06 | 34.91 |
| 2024-11-05 | 32.13 |
| 2024-11-04 | 32.09 |
| 2024-11-01 | 31.41 |
| 2024-10-31 | 31.51 |
| 2024-10-30 | 32.25 |
| 2024-10-29 | 31.79 |
| 2024-10-28 | 31.59 |
| 2024-10-25 | 31.38 |
| 2024-10-24 | 31.26 |
| 2024-10-23 | 31.32 |
| 2024-10-22 | 31.17 |
| 2024-10-21 | 31.14 |
| 2024-10-18 | 31.94 |
| 2024-10-17 | 31.29 |
| 2024-10-16 | 31.42 |
| 2024-10-15 | 31.00 |
| 2024-10-14 | 30.44 |
| 2024-10-11 | 30.52 |
| 2024-10-10 | 29.49 |
| 2024-10-09 | 29.94 |
| 2024-10-08 | 30.06 |
| 2024-10-07 | 29.65 |
| 2024-10-04 | 29.61 |
| 2024-10-03 | 29.69 |
| 2024-10-02 | 29.74 |